Actuate Therapeutics, Inc. Common stock (ACTU) Stock price, Description, News & Info

#Thinksabio latest news

Actuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh on Clinical Trial of Elraglusib in Combination with Retifanlimab and mFOLFIRINOX in Patients with Advanced Pancreatic Cancer